Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

ABT

Abbott Laboratories

Feb 04 • 04:00PM ET

129.10

Dollar change +0.65
Percentage change 0.51	%

Healthcare • Medical Devices • USA • NYSE

Peers: JNJ MDT DHR BAX SYK ISRG TDOC BDX RMD ZBH

| Held by: VTI VOO SPY IVV VTV XLV VIG IHI VYM VHT

Scroll to Statements

Index	S&P 500	P/E	16.85	EPS (ttm)	7.66	Insider Own	0.66%	Shs Outstand	1.73B	Perf Week	1.34%
Market Cap	223.92B	Forward P/E	22.64	EPS next Y	5.70	Insider Trans	-4.31%	Shs Float	1.72B	Perf Month	13.80%
Income	13.39B	PEG	1.60	EPS next Q	1.07	Inst Own	76.59%	Short Float	0.87%	Perf Quarter	13.87%
Sales	41.95B	P/S	5.34	EPS this Y	10.40%	Inst Trans	-0.82%	Short Ratio	2.62	Perf Half Y	15.98%
Book/sh	22.94	P/B	5.63	EPS next Y	10.61%	ROA	7.85%	Short Interest	14.97M	Perf Year	12.76%
Cash/sh	4.49	P/C	28.75	EPS next 5Y	10.51%	ROE	14.87%	52W Range	99.71 - 129.85	Perf YTD	14.14%
Dividend Est.	2.37 (1.84%)	P/FCF	34.52	EPS past 5Y	30.08%	ROI	25.44%	52W High	-0.58%	Beta	0.71
Dividend TTM	2.24 (1.74%)	Quick Ratio	1.14	Sales past 5Y	6.15%	Gross Margin	57.79%	52W Low	29.48%	ATR (14)	2.60
Dividend Ex-Date	Jan 15, 2025	Current Ratio	1.60	EPS Y/Y TTM	11.65%	Oper. Margin	16.44%	RSI (14)	73.17	Volatility	1.72% 2.16%
Employees	114000	Debt/Eq	0.38	Sales Y/Y TTM	4.59%	Profit Margin	31.91%	Recom	1.77	Target Price	135.41
Option/Short	Yes / Yes	LT Debt/Eq	0.32	EPS Q/Q	479.65%	Payout	29.22%	Rel Volume	1.22	Prev Close	128.45
Sales Surprise	-0.52%	EPS Surprise	0.32%	Sales Q/Q	7.16%	Earnings	Jan 22 BMO	Avg Volume	5.71M	Price	129.10
SMA20	7.61%	SMA50	10.28%	SMA200	15.85%	Trades		Volume	6,957,675	Change	0.51%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-08-24	Initiated	Oppenheimer	Outperform	$130
Sep-19-24	Initiated	Piper Sandler	Overweight	$131
Jul-30-24	Downgrade	Edward Jones	Buy → Hold
May-30-24	Initiated	Goldman	Buy	$121
Jul-21-23	Upgrade	Wolfe Research	Underperform → Peer Perform
May-30-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$112
Apr-20-23	Reiterated	Wolfe Research	Underperform	$107 → $103
Apr-20-23	Reiterated	UBS	Buy	$117 → $130
Apr-20-23	Reiterated	Raymond James	Outperform	$116 → $123
Apr-20-23	Reiterated	JP Morgan	Overweight	$118 → $122
Apr-20-23	Reiterated	Bernstein	Outperform	$132 → $133
Apr-20-23	Reiterated	Barclays	Overweight	$125 → $127
Mar-29-23	Initiated	UBS	Buy	$117
Oct-26-22	Initiated	Mizuho	Neutral	$105
Oct-18-22	Initiated	Barclays	Overweight	$118
Oct-12-22	Initiated	Jefferies	Hold	$110
Jul-06-22	Initiated	Wolfe Research	Underperform	$95
Mar-02-22	Resumed	BofA Securities	Buy	$140
Jan-27-22	Reiterated	UBS	Buy	$138 → $142
Jan-27-22	Reiterated	Raymond James	Outperform	$150 → $143

Show Previous Ratings

Feb-04-25 11:27AM	Abbott's 'Above the Bias' Film Reveals Misconceptions Can Impact Diabetes Care (PR Newswire)
06:02AM	Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories (GuruFocus.com)
Feb-03-25 07:45AM	2 Unstoppable Dividend Stocks That Will Pay You for Life (Motley Fool)
Feb-02-25 04:08PM	Why Abbott Laboratories (ABT) Is Among the Best Cancer Stocks to Buy According to Hedge Funds (Insider Monkey)
Feb-01-25 01:14PM	Musks X Adds Nestlé, Colgate, Shell, Other Brands to Ad-Boycott Suit (The Wall Street Journal)
02:42PM	Loading…
Jan-31-25 02:42PM	Abbott Laboratories (NYSE:ABT) Posts Q4 Sales In Line With Estimates (StockStory)
Jan-29-25 10:15PM	Abbott Laboratories (ABT): How Hot Money Found Its Way Into This Healthcare Giant (Insider Monkey)
11:26AM	Jim Cramer Says Abbott Laboratories (ABT) Was The Market Leader Yesterday. Thats New (Insider Monkey)
Jan-28-25 09:00AM	Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock (Zacks)
06:02AM	The Art of Valuation: Discovering Abbott Laboratories's Intrinsic Value (GuruFocus.com)
Jan-27-25 12:01PM	Abbott Laboratories: A Significant Addition to Eaton Vance Worldwide Health Sciences Fund (GuruFocus.com)
Jan-26-25 01:25PM	Jim Cramer Recommends Abbott Laboratories (ABT) Their Legal Stuff Is Largely Behind Them (Insider Monkey)
Jan-24-25 07:14PM	Analyst Report: Abbott Laboratories (Morningstar Research)
Jan-23-25 07:06AM	Abbott reports Q4 adjusted EPS $1.34, consensus $1.34 (TipRanks)
04:15AM	My Top 5 Stocks to Buy in Early 2025 (Motley Fool)
02:03AM	Loading…
02:03AM	Abbott Laboratories (ABT) Q4 2024 Earnings Call Highlights: Strong Growth Across Key Segments ... (GuruFocus.com)
01:26AM	Q4 2024 Abbott Laboratories Earnings Call (Thomson Reuters StreetEvents)
Jan-22-25 05:45PM	Analyst Report: Abbott Laboratories (Morningstar Research)
04:03PM	Abbott Shrugs Off 'Middling' Quarter As 2025 Sales Guidance, Diabetes Tech Shine (Investor's Business Daily)
01:15PM	Abbott Laboratories (ABT) Q4 2024 Earnings Call Transcript (Motley Fool)
11:40AM	Abbott Laboratories Stock Turns Positive. What to Know From Its Earnings. (Barrons.com)
11:32AM	Abbott Labs misses Q4 sales estimates (Yahoo Finance Video)
11:13AM	Is Abbott Laboratories (ABT) Expected to Post Impressive Earnings This Week? (Insider Monkey)
10:18AM	Abbott Laboratories Posts 'Middling' Quarter, But Diabetes Devices Shine (Investor's Business Daily)
10:17AM	Abbott Labs Q4 Earnings And Q1 Profit Guidance Lags Street View, Worldwide COVID-19 Testing Sales Fall (Benzinga)
09:30AM	Compared to Estimates, Abbott (ABT) Q4 Earnings: A Look at Key Metrics (Zacks)
08:50AM	Abbott Laboratories Slides On Light Fourth-Quarter Sales, In-Line Profit (Investor's Business Daily)
08:15AM	Abbott (ABT) Q4 Earnings Meet Estimates (Zacks)
07:12AM	Abbott: Q4 Earnings Snapshot (Associated Press Finance)
07:02AM	Abbott forecasts first-quarter profit below estimates (Reuters)
07:00AM	Loading…
07:00AM	Abbott Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Financial Outlook (PR Newswire)
06:01AM	Unlocking Intrinsic Value: Analysis of Abbott Laboratories (GuruFocus.com)
Jan-21-25 07:00PM	P&G earnings, mortgage applications: What to Watch (Yahoo Finance Video)
06:00AM	Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever. (Motley Fool)
Jan-19-25 06:21AM	Jim Cramer on Abbott Laboratories (ABT): I Think Abbott Will Win These Baby Formula Cases (Insider Monkey)
05:00AM	What To Expect in the Markets This Week (Investopedia)
Jan-15-25 11:33AM	Jim Cramer on Abbott Laboratories (ABT): Not Understood Very Well Because Theyre Doing Tremendous Stuff When It Comes To Diabetes. People Dont Seem To Care (Insider Monkey)
09:00AM	Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know (Zacks)
06:01AM	Unlocking Intrinsic Value: Analysis of Abbott Laboratories (GuruFocus.com)
Jan-13-25 06:00PM	Abbott (ABT) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jan-08-25 07:16PM	Analyst Report: Abbott Laboratories (Morningstar Research)
06:01AM	Abbott Laboratories: An Exploration into Its Intrinsic Value (GuruFocus.com)
Jan-06-25 06:00PM	Abbott (ABT) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
09:38AM	Is Abbott Laboratories (NYSE:ABT) the Best January Dividend Stock to Buy? (Insider Monkey)
09:00AM	LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer (Business Wire)
Jan-03-25 07:36PM	Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories (GuruFocus.com)
09:40AM	Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year? (Zacks)
Jan-02-25 09:00AM	Abbott Hosts Conference Call for Fourth-Quarter Earnings (PR Newswire)
08:00AM	3 Dividend Growth Beasts That Have Raised Their Payouts for a Combined 165 Years (Motley Fool)
Jan-01-25 12:45PM	Jim Cramer's Take on Abbott Laboratories (ABT): Bold Predictions for the Future (Insider Monkey)
09:00AM	Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Dec-30-24 06:00PM	Abbott (ABT) Dips More Than Broader Market: What You Should Know (Zacks)
Dec-28-24 06:59AM	Why Is Abbott Laboratories (ABT) Among Diamond Hill Capital's Top Stock Picks? (Insider Monkey)
04:15AM	2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now (Motley Fool)
Dec-25-24 10:15AM	Abbott, DexCom settlement not a complete surprise, says Wells Fargo (TipRanks)
06:01AM	The Art of Valuation: Discovering Abbott Laboratories's Intrinsic Value (GuruFocus.com)
05:30AM	DexCom, Abbott agree to settle patent litigation (TipRanks)
Dec-24-24 05:50PM	Abbott (ABT) Ascends But Remains Behind Market: Some Facts to Note (Zacks)
Dec-23-24 06:00PM	Abbott (ABT) Rises Yet Lags Behind Market: Some Facts Worth Knowing (Zacks)
Dec-19-24 06:00AM	2 Top Dividend Stocks to Buy and Hold Through 2025 and Beyond (Motley Fool)
Dec-18-24 05:15AM	The Smartest Dividend Stocks to Buy With $500 Right Now (Motley Fool)
Dec-17-24 05:50PM	Abbott (ABT) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
04:03PM	Abbott's FreeStyle Libre® 2 Now Reimbursed for Children and Adults Living with Diabetes in Alberta (PR Newswire)
07:00AM	Abbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the Heart (PR Newswire)
Dec-13-24 01:21PM	Abbott Increases Dividend Again, Showcasing Decades of Reliable Shareholder Returns (GuruFocus.com)
10:58AM	Abbott Increases Quarterly Dividend for 53rd Consecutive Year (PR Newswire)
Dec-12-24 09:00AM	On Ozempic? Big Food Makers Have a New Label for You (The Wall Street Journal)
09:00AM	Big Foods Latest Label: GLP-1 Friendly (The Wall Street Journal)
Dec-11-24 05:50PM	Abbott (ABT) Stock Sinks As Market Gains: Here's Why (Zacks)
06:01AM	Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories (GuruFocus.com)
Dec-09-24 10:38PM	Why Is Abbott Laboratories (ABT) Among the Best Dividend Kings to Invest In For Safe Dividend Growth? (Insider Monkey)
Dec-07-24 09:14PM	University of Nebraska Wins the Abbott and Big Ten Conference's Nationwide 'We Give Blood Drive' Competition, Receives $1 Million Grant from Abbott (PR Newswire)
Dec-05-24 05:50PM	Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
09:30AM	Brokers Suggest Investing in Abbott (ABT): Read This Before Placing a Bet (Zacks)
Dec-04-24 09:00AM	Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock (Zacks)
Nov-29-24 05:50PM	Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors (Zacks)
Nov-27-24 06:00AM	Unlocking Intrinsic Value: Analysis of Abbott Laboratories (GuruFocus.com)
Nov-25-24 04:05PM	InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of Directors (GlobeNewswire)
07:00AM	Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis (PR Newswire)
Nov-22-24 12:21PM	2 Dividend Kings to Buy for a Lifetime of Passive Income (Motley Fool)
Nov-20-24 09:00AM	Is Trending Stock Abbott Laboratories (ABT) a Buy Now? (Zacks)
Nov-19-24 09:30AM	Wall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy? (Zacks)
Nov-18-24 10:00AM	Inside a $400 billion bet on the brain-computer interface revolution (Yahoo Finance)
06:00AM	Abbott Opens State-of-the-Art Global Manufacturing Facility in Kilkenny, Ireland (PR Newswire)
Nov-16-24 07:19PM	Abbott Laboratories (ABT): A Magnificent Dividend Growth Stock to Buy Now (Insider Monkey)
Nov-14-24 06:19AM	3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years (Motley Fool)
Nov-13-24 10:28AM	US transcatheter tricuspid valve repair market grows by over 50% since launch in Q2 2024 (Medical Device Network)
06:00AM	Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories (GuruFocus.com)
Nov-08-24 09:16AM	If You Invested $10,000 In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now? (Benzinga)
04:15AM	Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever (Motley Fool)
Nov-07-24 10:39AM	Abbott Laboratories (ABT) Makes It On UBS List Of Stocks For The AI, Growth & Low Rates Era (Insider Monkey)
Nov-05-24 09:00AM	Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know (Zacks)
07:26AM	Abbott price target raised to $149 from $143 at Barclays (TipRanks)
Nov-04-24 06:06PM	Is Abbott Laboratories (ABT) the Best Pharma Stock to Buy Right Now? (Insider Monkey)
Nov-01-24 04:09PM	Abbott Surges After Avoiding Another 'Eye-Popping' Verdict In Baby Formula Trial (Investor's Business Daily)
03:55PM	Abbott, Reckitt found not liable in baby formula case. Stocks rise. (Yahoo Finance Video)
11:11AM	Reckitts Mead Johnson, Abbott cleared by US court in infant-formula case (Just Food)
10:24AM	Abbott, Reckitt Stocks Gain as Baby Formula Makers Score Rare Legal Win (Investopedia)
09:44AM	Abbott, Reckitt Stocks Rise on Baby-Formula Lawsuit Win (The Wall Street Journal)
07:16AM	Abbott shares rise after securing first win in premature infant formula trial (Reuters)

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Jan 29 '25	Option Exercise	38.40	131,360	5,044,224	316,166	Jan 31 07:16 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Jan 30 '25	Option Exercise	38.40	58,428	2,243,635	243,234	Jan 31 07:16 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Jan 29 '25	Sale	128.35	131,360	16,859,675	184,806	Jan 31 07:16 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Jan 30 '25	Sale	128.07	58,428	7,482,629	184,806	Jan 31 07:16 PM
Salvadori Daniel Gesua Sive	EXECUTIVE VICE PRESIDENT	Jan 30 '25	Option Exercise	38.40	23,771	912,806	149,468	Jan 31 07:08 PM
Salvadori Daniel Gesua Sive	EXECUTIVE VICE PRESIDENT	Jan 30 '25	Sale	128.50	23,771	3,054,574	125,697	Jan 31 07:08 PM
Morrone Louis H.	EXECUTIVE VICE PRESIDENT	Jan 28 '25	Sale	127.39	2,644	336,819	0	Jan 30 07:33 PM
Hubert L. Allen	Officer	Jan 30 '25	Proposed Sale	128.07	58,428	7,482,628		Jan 30 05:33 PM
Daniel Gesua Sive Salvadori	Officer	Jan 30 '25	Proposed Sale	128.50	23,771	3,054,573		Jan 30 05:26 PM
Hubert L. Allen	Officer	Jan 29 '25	Proposed Sale	128.35	131,360	16,859,675		Jan 29 05:30 PM
Funck, Jr. Robert E.	Officer	Nov 04 '24	Proposed Sale	120.00	15,000	1,800,000		Nov 04 04:02 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Oct 21 '24	Option Exercise	47.00	157,421	7,398,787	342,227	Oct 23 05:10 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Oct 21 '24	Sale	117.04	157,421	18,424,298	184,806	Oct 23 05:10 PM
ALLEN HUBERT L	Officer	Oct 21 '24	Proposed Sale	118.89	157,421	18,715,783		Oct 21 04:08 PM
Ford Robert B	CHAIRMAN AND CEO	Sep 12 '24	Option Exercise	47.19	141,679	6,685,975	361,738	Sep 13 05:24 PM
Ford Robert B	CHAIRMAN AND CEO	Sep 12 '24	Sale	116.41	141,679	16,493,218	220,059	Sep 13 05:24 PM
Robert B. Ford	Officer	Sep 12 '24	Proposed Sale	116.41	141,679	16,492,852		Sep 12 06:20 PM
MCCOY JOHN A. JR.	VICE PRESIDENT	Sep 04 '24	Sale	114.83	27	3,100	18,681	Sep 04 07:52 PM
Funck, Jr. Robert E.	Officer	Sep 04 '24	Proposed Sale	115.00	30,000	3,450,000		Sep 04 04:04 PM
Funck, Jr. Robert E.	EXECUTIVE VICE PRESIDENT	May 10 '24	Option Exercise	47.00	10,097	474,559	221,438	May 14 05:35 PM
Funck, Jr. Robert E.	EXECUTIVE VICE PRESIDENT	May 10 '24	Sale	104.57	10,097	1,055,819	211,341	May 14 05:35 PM
Earnhardt Lisa D	EXECUTIVE VICE PRESIDENT	May 07 '24	Sale	106.25	22,852	2,428,119	61,462	May 08 05:00 PM
Salvadori Daniel Gesua Sive	EXECUTIVE VICE PRESIDENT	Mar 01 '24	Sale	118.50	963	114,116	125,697	Mar 04 07:18 PM
Morrone Louis H.	EXECUTIVE VICE PRESIDENT	Mar 01 '24	Sale	118.50	801	94,918	62,968	Mar 04 07:14 PM
Moreland Mary K	EXECUTIVE VICE PRESIDENT	Mar 01 '24	Sale	118.50	676	80,106	91,260	Mar 04 07:09 PM
MCCOY JOHN A. JR.	VICE PRESIDENT	Mar 01 '24	Sale	118.50	472	55,932	18,760	Mar 04 07:05 PM
Earnhardt Lisa D	EXECUTIVE VICE PRESIDENT	Mar 01 '24	Sale	118.50	694	82,239	84,314	Mar 04 06:50 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Mar 01 '24	Sale	118.50	853	101,080	184,806	Mar 04 06:39 PM
Wainer Andrea F	EXECUTIVE VICE PRESIDENT	Feb 23 '24	Option Exercise	59.94	12,500	749,250	91,204	Feb 27 06:13 PM
Wainer Andrea F	EXECUTIVE VICE PRESIDENT	Feb 23 '24	Sale	120.00	12,500	1,500,000	78,704	Feb 27 06:13 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABT

Abbott Laboratories

Upgrade your FINVIZ experience